All Pharma News
Merck scores a new Zerbaxa indication

Merck scores a new Zerbaxa indication
Eric Sagonowsky FIERCE PHARMA
05 Jun 2019
Share Share
Merck set to seek EU, US approval of Zerbaxa for pneumonia

Merck set to seek EU, US approval of Zerbaxa for pneumonia
Matthew Dennis FIRST WORD PHARMA
12 Sep 2018
Share Share
Merck heralds a rare Big Pharma success for antibiotic PhIII, but..

Merck heralds a rare Big Pharma success for antibiotic PhIII, but..
John Carroll ENDPTS
11 Sep 2018
Share Share
Kaleido Biosciences Emerges From Stealth Mode With $65 Million

Kaleido Biosciences Emerges From Stealth Mode With $65 Million
Mark Terry BIOSPACE
18 Sep 2017
Share Share
Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers

Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers
Eric Sagonowsky FIERCE PHARMA
18 Jan 2017
Share Share
Amplyx Pharmaceuticals Appoints Ciara Kennedy, Ph.D., as President and CEO

Amplyx Pharmaceuticals Appoints Ciara Kennedy, Ph.D., as President and CEO
PR NEWSWIRE
05 Jan 2017
Share Share
Magenta Bags $48.5M & Will be Helmed by Former GlaxoSmithKline R&D Head

Magenta Bags $48.5M & Will be Helmed by Former GlaxoSmithKline R&D Head
Alex Keown BIOSPACE
17 Nov 2016
Share Share
Merck lines up for a quick approval with its C. diff therapy

Merck lines up for a quick approval with its C. diff therapy
Damian Garde FIERCE BIOTECH
28 Jan 2016
Share Share
Behind-the-scenes at Cards Against Biotechnology, Cubist`s snarky `last hurrah`

Behind-the-scenes at Cards Against Biotechnology, Cubist`s snarky `last hurrah`
Emily Wasserman FIERCE PHARMA MARKETING
30 Nov 2015
Share Share
Teva wagers up to $410M on Heptares` migraine program

Teva wagers up to $410M on Heptares` migraine program
Damian Garde FIERCE BIOTECH
26 Nov 2015
Share Share